drugset / Trial / NCT03970720

Restoration of Hypoglycemia Awareness With Metoclopramide

NCT03970720

RandomizedParallel-groupDouble-blindTreatment

Summary

Metoclopramide is a drug approved by the FDA for gastroesophageal reflux and to relieve symptoms in adults with acute and recurrent diabetic gastroparesis. The objective of this study is to determine whether metoclopramide can improve hypoglycemia awareness and decrease the incidence of hypoglycemia in type 1 diabetes patients with hypoglycemia unawareness.

Timeline

Start
2019-05-28
Primary completion
2027-06-30
Completion
2027-12-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Metoclopramide Small molecule 10 mg

Indications

No indication recorded.